Efficacy, Safety, pharmacokinetiсs, Immunogenicity of GNR-067 and Lucentis®

Clinical trial NCT04667039 · UNKNOWN

Trial details

NCT number: NCT04667039
Sponsor: AO GENERIUM
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Age Related Macular Degeneration (ARMD)

Start date: 2022-03-20
Primary completion: 2024-08-15
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.